glp 1 for alzheimer's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in and Parkinson's Diseases | CNS Drugs Blockbuster GLP-1 Diabetes and Weight

SC drafted the manuscript

The injectable, which is aimed at adults struggling with excess weight and for adolescents aged 1217 over 60 kilograms (132 lbs), is the first and only generic GLP-1 currently available

Recently, it was shown that cysteine uptake via excitatory amino acid carrier 1 suppresses ischemia-induced neuronal death through promotion of hippocampal GSH synthesis in ischemic animal models (162)

SURMOUNT-4 reported over 50% regain after tirzepatide withdrawal

Regulatory Perspectives and Approval Status The path to regulatory approval for new medications, especially those targeting complex conditions like obesity, is rigorous and involves extensive evaluation to ensure both safety and efficacy